Selecta Biosciences to Participate at the LifeSci Partners Genetic Medicines Summit 2021
Selecta Biosciences, Inc. (NASDAQ: SELB) announced that its CEO, Carsten Brunn, Ph.D., will present a corporate update at the LifeSci Partners Genetic Medicines Summit 2021 on June 22 at 9:30 a.m. ET. This event will highlight Selecta's ImmTOR™ platform, which develops tolerogenic therapies to mitigate unwanted immune responses. To register for the presentation, a link is provided. An archived webcast will also be available on the company's website, detailing Selecta's clinical-stage advancements in gene and enzyme therapies.
- None.
- None.
WATERTOWN, Mass., June 14, 2021 (GLOBE NEWSWIRE) -- Selecta Biosciences, Inc. (NASDAQ: SELB), a biotechnology company leveraging its clinically validated ImmTOR™ platform to develop tolerogenic therapies that selectively mitigate unwanted immune responses, today announced that Selecta’s Chief Executive Officer, Carsten Brunn, Ph.D., will provide a corporate update at the LifeSci Partners Genetic Medicines Summit 2021 on Tuesday, June 22 at 9:30 a.m. ET.
To register in advance for the presentation, please click here. An archived webcast will also be accessible in the Investors & Media section of the company’s website at www.selectabio.com.
About Selecta Biosciences, Inc.
Selecta Biosciences Inc. (NASDAQ: SELB) is a clinical stage biotechnology company leveraging its ImmTOR™ platform to develop tolerogenic therapies that selectively mitigate unwanted immune responses. With a proven ability to induce tolerance to highly immunogenic proteins, ImmTOR has the potential to amplify the efficacy of biologic therapies, including redosing of life-saving gene therapies, as well as restore the body’s natural self-tolerance in autoimmune diseases. Selecta has several proprietary and partnered programs in its pipeline focused on enzyme therapies, gene therapies, and autoimmune diseases. Selecta Biosciences is headquartered in the Greater Boston area. For more information, please visit www.selectabio.com.
For Investors:
Bruce Mackle
LifeSci Advisors, LLC
+1-929-469-3859
bmackle@lifesciadvisors.com
For Media:
Brittany Leigh, Ph.D.
LifeSci Communications, LLC
+1-646-751-4366
bleigh@lifescicomms.com
FAQ
What is the date of the Selecta Biosciences corporate update at the Genetic Medicines Summit 2021?
Who is presenting at the LifeSci Partners Genetic Medicines Summit for Selecta Biosciences?
What is the focus of Selecta Biosciences' ImmTOR™ platform?
Where can I find the archived webcast of the Selecta Biosciences presentation?
What stock symbol represents Selecta Biosciences?
